The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease
Frontiers in Immunology, 2019 Allogeneic hematopoietic cell transplantation (allo-HCT) is performed with curative intent for high- risk blood cancers and bone marrow failure syndromes; yet the development of acute and chronic graft-vs.-host disease (GVHD) remain preeminent causes of ...
David Bastian +4 more
doaj +2 more sources
AAV-mediated expression of HLA-G for the prevention of experimental ocular graft vs. host disease [PDF]
Molecular Therapy: Methods & Clinical Development, 2023 Ocular graft versus host disease (OGvHD) develops after allogeneic hematopoietic stem cell transplantation (HSCT) and manifests as ocular surface inflammatory disease.
Jacob P. Nilles +8 more
doaj +2 more sources
Frontiers in Bioengineering and Biotechnology, 2018 The most effective treatment of steroid refractory acute graft vs. host disease (aGvHD) is not yet established and mesenchymal stem cells (MSC) appear to be a promising therapy for the condition. We report single center case series of three patients, who
Maja Česen Mazič +4 more
doaj +2 more sources
Post-Transplant Cyclophosphamide for the Prevention of Graft-vs.-Host Disease in Allogeneic Hematopoietic Cell Transplantation: A Guide to Management for the Advanced Practitioner. [PDF]
J Adv Pract Oncol, 2023 Kachur E +4 more
europepmc +3 more sources
Case report: Sudden onset optic neuritis shortly after SARS-CoV-2 vaccination in an allogeneic hematopoietic stem cell transplant recipient with chronic graft-vs.-host disease. [PDF]
Front Med (Lausanne), 2023 Chu C, Jiang SK, Shao YC, Yeh SP.
europepmc +3 more sources
FRI100 Lipoprotein X In Graft Vs. Host Disease Affecting Liver [PDF]
J Endocr Soc, 2023 Deepak Vedamurthy +4 more
europepmc +2 more sources
Graft-vs-Host Disease in a Liver Transplant Patient With COVID-19 Infection. [PDF]
ACG Case Rep J, 2023 Kiparizoska S, Nguyen V, Rangnekar AS.
europepmc +2 more sources
JAMA Network Open, 2021 Key Points Question Is ruxolitinib an option for patients with steroid-refractory chronic graft-vs-host disease, and what characteristics are associated with treatment response?
Hengwei Wu +10 more
semanticscholar +1 more source
Frontiers in Immunology, 2021 Histone deacetylase inhibitors are currently the most studied drugs because of their beneficial effects on inflammatory response. Emerging data from numerous basic studies and clinical trials have shown that histone deacetylase inhibitors can suppress ...
Xiaoxiao Xu +3 more
semanticscholar +1 more source
Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD
Biology, 2023 Graft-versus-host disease (GVHD) is a life-threatening systemic complication of allogeneic hematopoietic stem cell transplantation (HSCT) characterized by dysregulation of T and B cell activation and function, scleroderma-like features, and multi-organ ...
Deepika Raman +7 more
doaj +1 more source